Diabetes Mellitus
Conditions
Interventions
Experimental group - 10 patients with type 2 diabetes will be submitted to 3 sessions of acupuncture, being monitored for 14 days using the Free system.
Control group - 10 patients with type 2 diabete
Device
Procedure/surgery
E02.190.044
Sponsors
Instituto de Ciências Farmacêuticas
Instituto de Ciências Farmacêuticas
Eligibility
Age
20 Years to 75 Years
Inclusion criteria
Inclusion criteria: Research participants should be able to clearly understand and cooperate with all the procedures described in the Study Consent Form, including completing the questionnaires. Men and women between the ages of 20 and 75; Patients with type 2 diabetes for at least 3 years with stable glycemic control; verified by the A1c dosage in the last 3 months without change of medication.
Exclusion criteria
Exclusion criteria: Use of synthetic glucocorticoids * such as prednisone, prednisolone, methylprednisolone and hydrocortisone by oral or topical routes. Pregnancy; Type 1 Diabetes; Antecedents or suspected nephrotic syndrome, hepatic insufficiency, hyperthyroidism, acromegaly, renal failure; Use of insulin to treat diabetes
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| No secondary outcomes are expected. | — |
Primary
| Measure | Time frame |
|---|---|
| Improvement in mean glycemia by at least 20 mg / dl in the 14 days of treatment. The average glycemia will be evaluated by the free style glucose sensor, with continuous monitoring for 14 days and downloading in specific software. | — |
Countries
Brazil
Contacts
Public ContactSérgio Vencio
Instituto de Ciências Farmacêuticas
Outcome results
None listed